Request for Proposals (RFP) Notice: Preclinical Prevent Cancer Program: Toxicology and Pharmacology Testing

Notice Number: NOT-CA-15-014

Key Dates
Release Date:  February 13, 2015

Related Announcements

Issued by
National Cancer Institute (NCI)


The National Cancer Institute (NCI) announces the release of a Broad Agency Announcement  on "Preclinical Prevent Cancer Program: Toxicology and Pharmacology Testing".

This Broad Agency Announcement (RFP N01CN45009-45) is available on the web site of the Office of Acquisitions (OA), NCI at  with instructions for submission of proposals and evaluation criteria.  For the complete solicitation package posted on Federal Business Opportunities site ( see

It is anticipated that multiple Indefinite Delivery Indefinite Quantity (IDIQ) type contracts will be awarded from Request for Proposal number N01CN45009-45. As a result, multiple Task Orders will be competed to support the conduct of toxicological and pharmacological evaluations of potential cancer preventive agents for Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for Phase 0, 1-3 clinical studies, New Drug Applications (NDA) to the FDA, and to select appropriate first-in-human (FIH) doses.

This IDIQ contract shall require the Contractor to perform studies in four areas: genotoxicity testing; general toxicology in experimental animals; reproductive toxicology studies in rodents and rabbits; and, specialized studies

The successful Offeror shall be able to perform work in all Task areas as outlined in the RFP and supporting documentation.


Please direct all inquiries to:

Dawn Albertini
National Cancer Institute (NCI)
Telephone: 301-624-8760